Analyst Price Target is $292.75
▲ +3.32% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Masimo in the last 3 months. The average price target is $292.75, with a high forecast of $310.00 and a low forecast of $276.00. The average price target represents a 3.32% upside from the last price of $283.35.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in Masimo. This Buy consensus rating has held steady for over two years.
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.